Summary
Companies
FTSE 100 up 0.23%, FTSE 250 rises 0.82%
Kingfisher surges on raising full-year profit forecast
Serco rises on $972 million US Air Force contract
Sterling dips after gloomy PMI surveys
Sept 23 (Reuters) – London stocks edged higher on Tuesday, led by retailers, while a weaker sterling further boosted the exporter-heavy FTSE 100 index.
The benchmark FTSE 100 (.FTSE), opens new tab rose 0.23% at 0959 GMT while the domestically focused FTSE 250 (.FTMC), opens new tab gained 0.82%.
Sign up here.
An index of retailers’ stocks (.FTNMX404010), opens new tab rose about 3%, boosted by a 15.2% surge in Kingfisher (KGF.L), opens new tab after the home improvement retailer raised its full-year profit outlook after a better-than-expected first half. Its shares were on track for their highest single-session percentage gain since 1986.
Other major retailers also advanced, with JD Sports Fashion (JD.L), opens new tab rising 1.6%, Frasers (FRAS.L), opens new tab up 2.3%, and Howden Joinery (HWDN.L), opens new tab gaining 3.5%.
The pound weakened, giving a further lift to export-oriented firms, after a survey showed British business activity slowed in early September.
Meanwhile, a separate survey showed on Tuesday that British firms have reported a loss of momentum and confidence ahead of possible new tax increases in Finance Minister Rachel Reeves’ next budget in November. It also showed another drop in hiring.
Last week, the Bank of England held its benchmark rate at 4% and said it is monitoring for signs that inflation pressures are waning before it reduces borrowing costs again.
Among other stocks, Serco Group (SRP.L), opens new tab was among the top gainers in the FTSE 250, up 4.4%, after a unit of the British outsourcing firm secured a contract to provide training and simulator services to the U.S. Air Force.
Engineering firm Smiths Group (SMIN.L), opens new tab reported profit and revenue above market estimates, helped by strong demand for upgraded baggage-screening detectors and a recovery in the semiconductor market. Its shares hit an all-time high in early trading but later fell 0.8%.
The broader healthcare sector (.FTNMX201030), opens new tab declined 1.3% with Oxford BioMedica’s (OXB.L), opens new tab 9.2% loss after the British cell and gene therapy manufacturer reported its half-year results.
Eyes were also on GSK (GSK.L), opens new tab as U.S. President Donald Trump’s administration asked drug companies to be prepared to ramp up production of leucovorin, a form of folic acid, as a treatment for some autism patients. GSK previously manufactured leucovorin and sold it under the name Wellcovorin.
Shares of the drugmaker fell 0.7% in early trading.
Reporting by Sanchayaita Roy in Bengaluru; Editing by Mrigank Dhaniwala